CVTX - CV Therapeutics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mopgcw	8/4/2006 1:49:57 AM
	Read Replies (1) of 411

yahoo summary of cc: 1. Managed Care: Medicate and Medicare understand the value of Ranexa. Just yesterday CVTX got an approval for coverage of 30,000,000 lives. Plus 70,000,000 covered lives with co-pay. At the present time 90% of all patients have access to Ranexa! This is a MAJOR achievement. We’ve heard from a few docs that one objection some patients had Ranexa's price. Now it is affordable and we should see it in the number of script growth. 2. The Speaker Program proved to be highly affective. Some of you remember that the plan was to recruit 500 doctors for this program, 1000 signed up. Tomorrow CVT is doing the 4th and last training of the remaining initially recruited docs. 120 dinner programs were already conducted. Since the effectiveness of the program is indisputable, CVTX is going to double the program size and train another 500 doctors. CVT also is going to higher 30 additional sales people and regroup existing sales force. ladyblrm

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next